Skip to main content
PLOS One logoLink to PLOS One
. 2025 May 12;20(5):e0307785. doi: 10.1371/journal.pone.0307785

Exploring breast cancer awareness and screening practices amongst rural women in The Gambia: Community-based cross-sectional study

Bakary Kinteh 1,2,*, Fatoumatta Jitteh 2,3, Mansour Badjie 1, Amadou Barrow 1,4,5, Lamin Jaiteh 2,3
Editor: Denekew Bitew Belay,6
PMCID: PMC12068578  PMID: 40354468

Abstract

Background

Breast cancer is a significant public health challenge in The Gambia, where it ranks as the second most commonly diagnosed cancer among women. Rural women face unique challenges in accessing screening services; however, evidence about their breast cancer awareness and screening uptake remains limited. This study aimed to assess breast cancer awareness and identify associated factors influencing screening uptake among rural women in The Gambia.

Methods

A community-based cross-sectional study was conducted among rural women in The Gambia. Using multistage sampling, we recruited 985 women from two local government authorities (response rate: 90.2%). Data were collected using a structured questionnaire administered in Kobo Toolbox. Descriptive statistics were used to summarize participant characteristics, while associations between predictors and breast cancer screening uptake were assessed using Chi-squared or Fisher’s exact test. Multivariable logistic regression was used to identify factors associated with screening uptake. Statistical significance was set at p<0.05 and adjusted odds ratios (aOR) with 95% confidence intervals were reported.

Results

The mean age of the study population was 32 years (standard deviation [SD]: ±12.6), with 34% aged 18–24 years. Although breast cancer awareness was high (87.7%), screening uptake was low (12.6%), primarily due to limited knowledge (58.7%), service unavailability (13.5%) and financial constraints (13.1%). Clinical breast examination was the most common screening method used (62.6%). Multivariable analysis revealed that Students (aOR=3.111, 95% CI: 1.453–6.663) and civil servants (aOR=2.778, 95% CI: 1.174–6.573) were more likely to undergo screening compared to unemployed women. Conversely, women with two (aOR=0.061, 95% CI: 0.005–0.791), three (aOR=0.075, 95% CI: 0.006–0.967), and five children (aOR=0.065, 95% CI: 0.005–0.877) were less likely to participate in screening compared to nulliparous women.

Conclusion

Despite the high awareness of breast cancer, screening uptake among rural women in The Gambia was notably low, primarily due to limited knowledge, service unavailability and financial constraints.

There is an urgent need for targeted interventions to improve screening uptake, particularly among multiparous women in rural communities.

Introduction

Breast cancer remains one of the most commonly diagnosed cancers among women and is a leading cause of cancer-related deaths in women, accounting for 23% of cancer cases and 14% of deaths worldwide [1]. The high morbidity and mortality rates do not exempt low and middle countries, where the incidence of breast cancer has been increasing rapidly, largely attributed to lifestyle changes, alterations in reproductive health factors, and longer life expectancy [2]. According to recent World Health Organization (WHO) reports, 157 of 185 countries registered breast cancer as the most prevalent cancer affecting women in 2022 [3].

In The Gambia, breast cancer is the second most commonly diagnosed cancer, second only to cervical cancers with an estimated prevalence of 11.25 per100, 000 women [4]. Recent data indicates that more than 50% of diagnosed patients died of the disease by 2020 [5]. The Cancer Registry Unit under the Ministry of Health was tasked with the country’s cancer data from diagnosis to treatment, faces significant challenges in meeting WHO’s initiative to reduce breast cancer mortality by 3 million lives by 2024 [3]. The current limitations in capacity include breast cancer diagnosis, treatment, and patient management, had significantly impacted breast cancer outcomes. Only 50% (52/102) of healthcare facilities can provide clinical diagnosis, and women often travel up to 45 km to access healthcare facilities (Sanyang et al. 2021). Evidence suggests a 3–6 month average delay between symptom onset and seeking healthcare [6], significantly affecting prognosis and survival rates. Multiple factors contribute to poor outcomes, including limited awareness, cultural beliefs, socio-economic barriers, and inadequate access to modern diagnostic facilities [7,8].

While a recent study among female university students showed relatively good breast cancer awareness, it revealed poor screening practices, with 75% never having undergone screening [9]. The study revealed that female university students had good knowledge about breast cancer; however, breast cancer screening uptakes were still poor, as up to 75% of the respondents had never undergone any form of breast cancer screening [9]. However, these findings may not represent rural women who face unique barriers to healthcare access and different socio-cultural contexts. Understanding breast cancer awareness and screening uptakes specifically among rural women is crucial for achieving WHO’s target of reducing mortality by 25% by 2030 and 40% by 2040 through the Global Breast Cancer Initiative (GBCI) strategies of early detection, timely diagnosis, and prompt treatment [3].

The Gambian Health Policy 2021–2023 acknowledges breast cancer as a major health concern, but implementation strategies remain limited [5]. This study therefore aimed to explore breast cancer awareness and screening uptake among rural Gambian women, identify associated factors influencing uptake, and inform targeted interventions and policy decisions for improving breast cancer outcomes in underserved rural communities.

Materials and methods

Study design and setting

We conducted a community-based cross-sectional study between January and February 2024 to assess breast cancer awareness and screening uptake among rural women residing in the two Local Government Authorities (LGAs) in the northern regions of The Gambia. The study area comprises: Kerewan Area Council with four districts (Upper Baddibu, Lower Baddibu, Central Baddibu, and Jokadu) and Kuntaur Area Council with three districts (Upper Saloum, Lower Saloum, and Niani), with populations of 225,516 and 98,966 inhabitants, respectively [10]. Each district contains an average of 20–30 communities. Healthcare delivery in these regions is structured hierarchically, with one General Hospital in Farafenni, District hospitals in Essau, Kerewan, and Kuntaur and primary healthcare facilities consisting of six major health centers and twenty-eight community health posts [5].

The average distance to the nearest health facility offering clinical breast examination services is 15–20 kilometers, with some communities located up to 40 kilometers away [11,12]. Public transportation is irregular, and road conditions are poor, particularly during the rainy season [13]. Most women must travel 2–3 hours to access these services, incurring significant transportation costs (approximately 200–300 Dalasi per trip, equivalent to 3–5 USD) [14]. Additionally, clinical breast examination services, while subsidized, still cost about 100 Dalasi (approximately 1.5 USD), representing a significant financial burden for many rural families. The nearest mammography services are available only at the Edward Francis Small Teaching Hospital in Banjul [12], requiring women to travel over 200 kilometers from most study communities [13]. This distance, combined with the high cost of mammography (approximately 2000 Dalasi or 30 USD), makes regular screening particularly challenging for rural women.

Study population

The study population comprised women aged ≥ 18 years residing in rural communities within two local government authorities in Northern Gambia. The eligibility criteria included a minimum residential duration of 12 months in the study communities prior to data collection, ensuring that the participants had adequate exposure to local healthcare services and community practices.

Study variables

The primary outcome variable was breast cancer screening uptake, measured as a binary variable (yes/no) based on whether the respondents had ever undergone any form of breast cancer screening (breast self-examination, clinical breast examination, or mammography) at least once in their lifetime. Independent variables included sociodemographic characteristics: age (categorized as 18–24, 25–31, 32–38, 39–45, and 46 years & above); ethnicity (Mandinka, Fula, Wolof, Serahuli, Jola, Serer, and others); religion (Islam, Christianity); nationality (Gambian, non-Gambian); educational level (no formal education, primary, secondary, and tertiary); current occupation (unemployed, civil servant, student, housewife, farmer, business, and others); marital status (single, married, divorced/separated, and widowed); and parity (nullipara, primipara, two, three, four, five, and six & above).

Sample size determination

The sample size was calculated using the Epi Info version 7.0 (Centers for Disease Control and Prevention, Atlanta, GA, USA). Assuming a 50% prevalence of breast cancer awareness (as no previous community-based studies were available), 99% confidence level, and precision of 5%, the minimum required sample size was determined using the following formula:

n = [Z21a/2 × P(1P)]/d2

where n is the sample size, Z₁₋ₐ/ is the standard normal variate at 99% confidence level (2.576), P is the expected proportion (50%), and d is the precision (5%). The calculated minimum sample size was 662 respondents. After accounting for a 10% non-response rate and a design effect of 1.5, owing to the multi-stage sampling technique, the final target sample size was 1,092. Of these, 985 completed the study, yielding a response rate of 90.2%.

Sampling strategy

A four-stage sampling method was employed. First, the northern region was purposively selected due to its geographical location, high population density of underserved rural women, and absence of mammography services. This selection aligns with the study’s aim of understanding screening uptake in rural, as it represents a significant proportion of rural communities with limited healthcare access. The northern region of The Gambia comprises of Kerewan and Kuntaur local government areas (LGAs), with (Upper Baddibu, Lower Baddibu, Central Baddibu, and Jokadu) and three (Upper Saloum, Lower Saloum, and Niani) districts, respectively. Second, five communities were randomly selected from each district, yielding 35 study communities in total. Third, within each selected community, households were sampled using probability proportional to size, selecting an average of 25–35 households per community. Finally, one eligible woman was selected from each household. In households with multiple eligible respondents, a participant was selected using a random number generator to ensure unbiased selection and minimize selection bias that could arise from choosing the most available or willing participant. When no eligible respondents were found in a selected household, it was documented as a non-eligible household in our response rate calculations, and data collectors proceeded to the next household following a predetermined clockwise direction until the required sample size was achieved.

Data collection instruments

Data were collected using a structured questionnaire adapted from a previous study of female university students in The Gambia (9), modified for community-level applications. The questionnaire was comprised of three main sections: sociodemographic characteristics, breast cancer awareness, and screening practices. Sociodemographic variables included age (in years), ethnicity, religion, nationality, educational level, current occupation, marital status, and parity. Breast cancer screening practices were assessed in four domains: screening history, screening method (breast self-examination, clinical breast examination, or mammography), facilitating factors for screening uptake, and barriers to screening.

The questionnaire was digitized using the Kobo Toolbox platform for electronic data capture. Data collectors were recruited from the University of The Gambia School of Medicine and Allied Health Sciences and the School of Public Health at Gambia College by the Solace Foundation. All data collectors underwent a one-day standardized training on the Kobo Toolbox application, interviewing techniques, and translation protocols for three major local languages (Mandinka, Wolof, and Fula), which collectively cover approximately 92% of the study area’s population. To ensure instrument reliability and consistency, the questionnaire was pilot tested among women in the West Coast Region prior to field implementation.

Field data collection was conducted from January 24–31, 2024, by 150 trained research assistants. Quality control measures included field supervision and real-time data monitoring using the Kobo Toolbox server. The dataset was subsequently exported to Microsoft Excel for data cleaning and validation. This systematic approach to data collection and management helped to ensure data quality and completeness throughout the study period.

Data management and statistical analysis

Data analysis was conducted using IBM SPSS Statistics version 28. Descriptive statistics such as means with standard deviations (SD) for continuous variables, and frequencies and percentages for categorical variables were used to present the women characteristics including their breast cancer awareness and screening practices. As appropriate, Pearson’s chi-squared or Fisher’s exact test was used to examine the associations between breast cancer screening uptake and potential covariates.

Prior to modeling, we assessed multicollinearity among predictor variables using variance inflation factors (VIF), where a VIF >10 was considered indicative of high multicollinearity. The educational level showed high collinearity with occupational status and was subsequently removed to prevent model overfitting. Despite its non-significance at the bivariate analysis level, ethnicity was retained in the model owing to its theoretical importance and our specific interest in understanding its effects on breast cancer screening uptake in relation to other predictors.

Variables with p-values <0.20 in the bivariate analysis were included in the multivariable model. This less conservative threshold was chosen to minimize Type II errors and retain potentially important predictors that might not meet the conventional p<0.05 criterion at the bivariate level. Despite its non-significance at the bivariate analysis level, ethnicity was retained in the model owing to its theoretical importance and our specific interest in understanding its effects on breast cancer screening uptake in relation to other predictors. We employed multivariable logistic regression owing to the binary nature of our outcome variable (breast cancer screening uptake: yes/no) and its suitability for modeling multiple predictors simultaneously while controlling for potential confounders. A backward stepwise selection method was used, starting with all eligible variables and iteratively removing the least significant predictors while retaining the variables of theoretical importance regardless of statistical significance.

To identify the predictors of breast cancer screening uptake, we fitted a multivariable logistic regression model in which the outcome variable Y was coded as Y=1 (screened) or Y=0 (not screened). The logistic model can be expressed as follows:

logit(p) = ln(p/1p) = β0 + β1X1 + β2X2 +... + βkXk

where p represents the probability of breast cancer screening uptake, β₀ is the intercept, and β through βk are the regression coefficients for the k independent variables (X...XK). The odds ratio (OR) for breast cancer screening uptake can be derived as:

OR = exp(β0 +β1X1 + β2X2 +... + βkXk)

where exp(β) represents the adjusted odds ratio (aOR) for the ith predictor variable (X), controlling for other variables in the model. Model estimates were reported as adjusted odds ratios (aORs) with 95% confidence intervals (CI). Statistical significance was declared at p<0.05.

Ethical considerations

Ethical approval for this study was obtained from the Research Ethics Committee (REC) of Edward Francis Small Teaching Hospital (EFSTH_REC_202–038). Permission to conduct the study within the communities was verbally obtained from community entry points, such as the Alkalos and Village Development Committees. Voluntary Informed consent was obtained from each study participant verbally or through a signed consent form, where participants could read or write before the onset of the interview and maintained throughout the data collection process.

Results

Women’s sociodemographic characteristics

As shown in Table 1, the mean age of respondents was 32 years (SD: ±12.6), with the largest proportion (34.0%) aged between 18–24 years. The sample was predominantly Muslim (99.5%) and Gambian (97.7%). Regarding ethnicity, Mandinka (39.0%) and Wolof (37.9%) were the most common groups, followed by Fula (15.3%). Educational attainment was generally low, with nearly half (46.2%) reporting no formal education, whereas only 11.0% had attained tertiary education. Occupationally, housewives constituted the largest group (30.1%), followed by farmers (19.9%), and business owners (15.4%). Most respondents were married (71.7%), 26.8% were nulliparous, and 16.8% had six or more children.

Table 1. Distribution of women’s socio-demographic characteristics by breast cancer screening uptake.

Variable Breast cancer screening uptake p-valve
n (%) No (%) Yes (%)
Age of respondents 0.235
 18–24 335 (34.0) 283 (84.5) 52 (15.5)
 25–31 263 (26.7) 238 (90.5) 25 (9.5)
 32–38 145 (14.7) 125 (86.2) 20 (13.8)
 39–45 102 (10.4) 91 (89.2) 11 (10.8)
 46 & above 140 (14.2) 124 (88.6) 16 (11.4)
Ethnicity 0.463a
 Mandinka 384 (39.0) 345 (89.8) 39 (10.2)
 Fula 153 (15.3) 129 (84.3) 24 (15.7)
 Wolof 373 (37.9) 323 (86.6) 50 (13.4)
 Serahuli 8 (0.8) 6 (75.0) 2 (25.0)
 Jola 44 (4.5) 37 (84.1) 7 (15.9)
 Serer 21 (2.1) 19 (90.5) 2 (9.5)
 Others 2 (0.2) 2 (100.0) 0 (0.0)
Religion 0.821a
 Islam 980 (99.5) 857 (87.4) 123 (12.6)
 Christianity 5 (0.5) 4 (80.0) 1 (20.0)
Nationality 0.423a
 Gambian 962 (100.0) 841 (87.4) 121 (12.6)
 Non-Gambian 23 (100.0) 20 (87.0) 3 (13.0)
Education level 0.006 *
 No formal education 455 (46.2) 405 (89.0) 50 (11.0)
 Primary education 164 (16.7) 145 (88.4) 19 (11.6)
 Secondary education 258 (26.2) 228 (88.4) 30 (11.6)
 Tertiary education 108 (11.0) 83 (76.9) 25 (23.1)
Current Occupation <0.001 * a
 Unemployed 123 (12.5) 111 (90.2) 12 (9.8)
 Civil servant 63 (6.4) 49 (77.8) 14 (22.2)
 Student 128 (13.0) 96 (75.0) 32 (25.0)
 Housewife 296 (30.1) 266 (89.9) 30 (10.1)
 Farmer 196 (19.9) 178 (90.8) 18 (9.2)
 Business 152 (15.4) 134 (88.2) 18 (11.8)
 Others 27 (2.7) 27 (100.0) 0 (0.0)
Marital status 0.870a
 Single 218 (22.1) 188 (86.2) 30 (13.8)
 Married 706 (71.7) 621 (87.9) 85 (12.1)
 Divorced/Separated 22 (2.3) 18 (81.8) 4 (18.2)
 Widowed 38 (3.9) 33 (86.8) 5 (13.2)
Parity <0.001 *
 Nullipara 264 (26.8) 219 (83.0) 45 (17.0)
 Primipara 144 (14.6) 134 (93.1) 10 (6.9)
 Two 125 (12.7) 115 (92.0) 10 (8.0)
 Three 89 (9.0) 71 (79.8) 18 (20.2)
 Four 104 (10.6) 97 (93.3) 7 (6.7)
 Five 91 (9.2) 76 (83.5) 15 (16.5)
 Six & above (Multipara) 165 (16.8) 148 (89.7) 17 (10.3)

*Statistical significance at p-value <0.05; a=Fisher’s exact test

Fig 1 presents the distribution of breast cancer screening uptake across sociodemographic characteristics. Overall, only 12.6% (n = 124) of respondents reported having ever undergone breast cancer screening, while 87.4% (n = 861) had never been screened.

Fig 1. Distribution of breast cancer screening uptakes (N=985).

Fig 1

Association between the selected women’s characteristics and breast cancer screening uptake

The Table 1 presents the association between the selected women’s characteristics and breast cancer screening. Chi-square analysis revealed significant associations between breast cancer screening uptake and education level, current occupation, and parity. Specifically, women with tertiary education reported the highest screening rates (23.1%), compared to those with no formal education (11.0%), primary education (11.6%), and secondary education (11.6%), χ²(3, N = 985) = 12.46, p =.006. Among occupational groups, students (25.0%) and civil servants (22.2%) demonstrated higher screening rates than housewives (10.1%), farmers (9.2%), and business owners (11.8%), χ²(5, N = 985) = 26.78, p <.001. Screening uptake was inversely associated with parity, as nulliparous women (17.0%) reported the highest screening rates compared to multiparous women with six or more children (10.3%), χ²(6, N = 985) = 22.64, p <.001. Other variables, including age, ethnicity, religion, nationality, and marital status, were not significantly associated with screening uptake. For example, screening rates among age groups ranged from 9.5% (25–31 years) to 15.5% (18–24 years), but this was not statistically significant, χ²(4, N = 985) = 5.34, p =.235. Similarly, ethnicity did not exhibit significant differences, with screening rates ranging from 0% (Other ethnicities) to 25.0% (Serahuli), χ²(6, N = 985) = 8.71, p =.463.

Breast cancer awareness

Table 2 below assessed breast cancer awareness among the respondents; the majority (87.7%) had heard about breast cancer prior to the study, and less than half (41.3%) reported mass media as their source of information. The majority of respondents identified obesity/overweight (35.2%), being a woman (35.0%), and having a family history of breast cancer (29.0%) as common risk factors for breast cancer. However, less than 14.5% of the respondents knew about clinical breast examinations and mammography (3.6%) as a means of early detection and diagnosis of breast cancer. Based on breast cancer prevention, the respondents identified early initiation of breastfeeding, physical exercise, and limited alcohol intake (38.8%, 37.8%, and 23.8%, respectively) as measures to prevent breast cancer among females. Nearly three-quarters (73.8%) were convinced that women of reproductive age should be screened for breast cancer.

Table 2. Breast cancer awareness of respondents.

variable n %
Heard about breast cancer (n=985)
 Yes 864 87.7
 No 121 12.3
Source of information*
 Family member 291 29.5
 Health worker 305 31.0
 Teacher 91 9.2
 Friends 277 28.1
 mass media 407 41.3
 Others 48 4.9
Knew risk factors of breast cancer*
 Obesity/Overweight 125 35.2
 Old age 164 16.6
 Family history of breast cancer 293 29.0
 Birth of first child after the age of 30 years 110 11.2
 Early onset of menses (before age 12) 83 8.4
 Late menopause (after 55 years) 49 5.0
 Late initiation of breastfeeding 121 12.3
 Being a woman 345 35.0
 Cigarettee smoking/Alcohol consumption 221 22.4
 Use of Oral contraceptive 82 8.3
 Exposure to radiation 235 23.2
Knew breast examination methods*
 Breast self-examination 101 10.5
 Clinical breast examination 147 14.5
 Mammography 36 3.6
Knew the preventive methods of breast cancer risk*
 Improve physical exercise 372 37.8
 Initiation of breast feeding 382 38.8
 Limit Alcohol intake 235 23.8
 Avoid hormonal replacement therapy 115 11.7
Knew who should be screen for breast cancer*
 Older women 404 41.0
 Adolescents 619 62.8
 Women in reproductive age 747 73.8
 Pregnant women 485 49.2

*Multiple responses

Breast cancer screening practices

Among those screened, clinical breast examination was the predominant method (62.6%), followed by breast self-examination (39.5%), whereas mammography utilization was minimal (1.1%) as shown in Table 3. Screening-seeking behavior was universally triggered by breast pain (100%), with additional motivation from healthcare worker recommendations (58.9%) and self-detected breast lumps (40.3%). Among the non-screened participants (n=861), the primary barriers to screening were lack of awareness about screening methods and services (58.7%), followed by service unavailability (13.5%), high associated costs (13.1%), forgetfulness (11.5%), and fear of finding a mass (11.3%).

Table 3. Distribution of breast cancer screening uptake.

Variables n %
Which breast screening method? (n=124)*
 Breast self-examination 49 39.5
 Clinical breast examination 78 62.6
 Mammography 14 1.1
Reasons for breast screening*
 Breast pain 124 100
 Notice a breast lump 50 40.3
 Advice from a health worker 73 58.9
 Reasons for not breast screening (n=861)*
 Lack of knowledge 505 58.7
 Forgetfulness 99 11.5
 Fear of the finding a mass 97 11.3
 Service unavailability 116 13.5
 High cost 113 13.1

*Multiple responses

Fig 2 shows that the majority of respondents were aware that swelling of all parts of the breast (48.2%), nipple pain (45.2%), and lumps (37.1%) were common signs and symptoms of breast cancer.

Fig 2. Distribution of breast cancer’s signs and symptoms.

Fig 2

Predictors of breast cancer screening uptake

Table 4 presents the results of multivariable logistic regression analysis examining factors associated with breast cancer screening uptake. After adjusting for potential confounders, occupation and parity emerged as significant predictors of screening uptake, whereas ethnicity showed varying but non-significant associations. In terms of occupation, students demonstrated the strongest positive association with screening uptake (aOR=3.111, 95% CI: 1.453–6.663, p=0.003), being three times more likely to undergo screening compared to unemployed women. Similarly, civil servants showed significantly higher odds of screening (aOR=2.778, 95% CI: 1.174–6.573, p=0.020) compared to the unemployed group. Other occupational categories, including housewives (aOR=1.022, 95% CI: 0.489–2.135), farmers (aOR=0.936, 95% CI: 0.413–2.122), and business owners (aOR=1.138, 95% CI: 0.506–2.560), showed no significant association with screening uptake. Regarding parity, women with two children (aOR=0.061, 95% CI: 0.005–0.791, p=0.032), three children (aOR=0.075, 95% CI: 0.006–0.967, p=0.047), and five children (aOR=0.065, 95% CI: 0.005–0.877, p=0.040) were significantly less likely to undergo screening compared to nulliparous women. This inverse relationship between parity and screening uptake suggests that women with children may face unique barriers in accessing screening services.

Table 4. Adjusted Odds Ratios of breast cancer screening uptake by women’s selected characteristics.

Variables aOR 95%CI p-value
Ethnicity
 Mandinka (ref) 1
 Fula 1.552 0.872 - 2.761 0.135
 Wolof 1.559 0.977 - 2.486 0.062
 Serahuli 1.359 0.541 - 3.387 0.517
 Jola 0.867 0.188 - 3.990 0.854
 Serer 2.821 0.521 - 15.267 0.229
Parity
 Nullipara (ref) 1
 Primipara 0.12 0.10 - 1.448 0.095
 Two 0.061 0.005 - 0.791 0.032*
 Three 0.075 0.006 - 0.967 0.047*
 Four 0.238 0.019 - 3.021 0.269
 Five 0.065 0.005 - 0.877 0.040*
 Six & Above (Multipara) 0.196 0.015 - 2.513 0.211
Current Occupation
 Unemployed (ref) 1
 Civil servant 2.778 1.174 - 6.573 0.020*
 Student 3.111 1.453 - 6.663 0.003*
 Housewife 1.022 0.489 - 2.135 0.954
 Farmer 0.936 0.413 - 2.122 0.875
 Business 1.138 0.506 - 2.560 0.755

*Statistical significance p<0.05, aOR, Adjusted Odds Ratio

Although not statistically significant, ethnic variations were observed, with Serer women showing nearly three times higher odds of screening (aOR=2.821, 95% CI: 0.521–15.267, p=0.229) compared to Mandinka women. Other ethnic groups, including Fula (aOR=1.552, 95% CI: 0.872–2.761) and Wolof (aOR=1.559, 95% CI: 0.977–2.486), showed modest but non-significant odds of participation in screening.

Discussion

To attain the target set by the WHO through the Global Breast Cancer Initiative (GBCI) in The Gambia, there is a need to target all three 3 priority areas to reduce both morbidity and mortality from breast cancer. Our study examined breast cancer awareness and current screening uptake among rural women in The Gambia. The findings revealed that nearly 9 out of ten rural women knew the term breast cancer before the study. This finding is similar to a study conducted by Kinteh et al. (2023) among female University Students, where all respondents heard of breast cancer before the study, and a study conducted in Gaza, where more than 80% of respondents also heard about breast cancer [15]. The findings on breast cancer awareness were three times higher than those of a study conducted in a rural South African setting where only 31% of respondents were aware of breast cancer [16] and a study conducted in Ethiopia, where almost half (49.87%) had never heard of self-breast-examinations [17].

Mass media serves as an efficient and effective means of disseminating information to people, and they are instrumental in health promotion and education. More than 40% of our respondents had heard of breast cancer through media programs. This is similar to research done in Ethiopia where 57.91% heard of breast cancer through Television/Radio [17] and in Addis Abba, 70.10% heard about breast cancer from TV/Radio [18]. The Directorate of Health Promotion and Education under the Ministry of Health of The Gambia is a media-friendly center that is responsive to current health issues and proactive in educating the population on common health problems in the country.

The respondents demonstrated an average awareness level of breast cancer risk factors. They correctly identified obesity/overweight (35.2%), female sex (35.0%), family history (29.0%), and cigarette smoking/alcohol consumption (22.4%) as risk factors for breast cancer. This finding is similar to that of a study conducted by (Ramathuba et al., 2015) in South Africa that showed the use of oral contraceptives and late menopause as less common risk factors. Similarities were also found in a study in Nigeria, where 11.8% and 18.7% of respondents reported late menopause and birth control pill use, respectively, as risk factors for breast cancer [19]. The country has low contraceptive uptake among reproductive women (19%) [13]; as such, respondents have limited knowledge of oral contraceptives as a risk factor for breast cancer. Conversely, knowledge about late menopause as a risk factor is lower than that reported in many studies in sub-Saharan Africa [9,17,2022].

This study identified a large awareness gap regarding breast cancer screening methods and diagnostics. Less than 15% of the respondents knew about clinical breast examinations, 10% knew about breast self-examinations, and up to 4% knew about mammography. This finding corroborates the spatial availability of breast cancer diagnostic services in the country, as reported by [12]. Efforts should be centered on improving breast cancer education, including knowledge of self-breast examinations and diagnostic methods that could improve women’s screening practices. Breast cancer prevention among women is a global target desirable for all stakeholders. The respondents advanced the initiation of breastfeeding (38.8%) and improved physical exercise (37.8%) as methods for preventing breast cancer in women. These are among the WHO-recommended preventive methods for breast cancer in women [3].

The respondents’ awareness of the tell-tale signs of the symptoms of breast cancer aligned around four major signs: swelling of the breast (48.2%), nipple pain(45.2%), breast lump (37.1%), and sores on the breast (26.8%). These findings are similar to those of studies conducted among women in Qatar, Southwest Ethiopia, Uganda, Cameroon, India, Nigeria and Northwest Ethiopia [17,2126]. However, there was limited awareness among the respondents regarding the signs of nipple discharge, retracted nipple, change in breast color, scaling, and thickening of the nipple, and efforts are needed to raise awareness. These findings highlight the complex interplay of structural, knowledge-based, and personal barriers influencing breast cancer screening uptake in this rural population, suggesting the need for targeted interventions to address these multiple barriers to screening.

The uptake of screening for breast cancer was low among respondents, as less than 13% had ever undergone any form of clinical breast examination. Among those who had been screened for breast cancer, more than 62% done clinical breast examination. Mammography was the least conducted (1.1%) breast cancer screening method among the respondents because of the unavailability of this screening method in rural areas, as evidenced by Sanyang et al., 2021, who found that breast cancer histopathological diagnosis and surgical management remain unavailable to over 50% of the population in The Gambia [12]. Breast Self-Examination, which is a simple and cost-free method of screening for breast diagnosis, was conducted by less than 40% of respondents. These findings are lower than those reported in studies conducted in Uganda (76.5%), Cameroon (47.0%), Northwest Ethiopia (45.8%), and Addis Ababa (43.6%) [18,2123]. However, the uptake of breast self-examination is higher than that in a similar study conducted in the southern parts of Ethiopia (21.1%) [27]. Variability in breast self-examination among countries could be associated with differences in social literacy. Eventually, breast pain was one of the reasons for uptake, and a lack of awareness was a major barrier to breast cancer screening in this study.

This study’s findings reveal a consistent inverse relationship between parity and breast cancer screening uptake, suggesting that women with children face unique barriers to accessing preventive healthcare services. This pattern might be attributed to competing priorities of childcare responsibilities, time constraints, and resource allocation within families. The decreased likelihood of screening among multiparous women highlights the need for targeted interventions that address the specific challenges faced by mothers, such as mobile screening services or community-based programs that integrate childcare support. Occupational status emerged as a crucial determinant of screening practices, with formal employment and educational engagement positively influencing screening behaviors. The higher screening rates among civil servants and students likely reflect a combination of factors including better health literacy, access to information, financial resources, and possibly health insurance coverage through employment. Unlike previous studies where education alone predicted screening uptake [23,27], our findings suggest that employment status and its associated benefits may be more influential in the rural Gambian context. This underscores the importance of workplace health programs and the need to extend similar advantages to women in informal employment sectors.

Strengths and limitations

Strengths

This study had several strengths. First, it is one of the few community-based studies to examine breast cancer screening uptake among rural women in The Gambia, providing crucial insights into healthcare-seeking behaviors in underserved populations. The high response rate (90.2%) and the inclusion of hard-to-reach communities enhanced the representativeness of the study. Additionally, the findings may be generalizable to other rural regions of The Gambia given the sociodemographic similarities between the northern and southern regions. The use of validated data collection tools and trained interviewers who could communicate in local languages further strengthens the validity of our findings.

Limitations

Several limitations of this study should be considered when interpreting our results. First, the cross-sectional design precludes the establishment of causal relationships between breast cancer screening uptake and the associated factors. Second, the self-reported nature of the data may have introduced social desirability and recall bias, potentially affecting the accuracy of screening uptake reports. Third, while we attempted to minimize information bias through validated questionnaires and trained interviewers, language barriers and varying interpretations of screening uptake might have influenced the responses, particularly in communities with low health literacy. Finally, we did not assess the quality and accessibility of the available screening services, which could provide additional information to the observed screening patterns.

Conclusion

This study provides important insights into breast cancer awareness and screening uptake among rural women in The Gambia. While awareness of breast cancer signs, symptoms, risk factors, and preventive measures was relatively high, screening uptake (12.6%) were substantially lower than the reported rates in other sub-Saharan African settings. The findings revealed significant disparities in screening uptake, with occupation and parity emerging as the key predictors. Specifically, women in formal employment (civil servants) and students showed higher screening rates, while increased parity was associated with a decreased screening likelihood. Despite the high awareness of breast cancer, screening uptake among rural women in The Gambia was notably low, primarily due to limited knowledge of screening methods, financial constraints, and service unavailability.

These findings underscore the urgent need for comprehensive interventions targeting both individual and systemic screening barriers. We recommend that the Ministry of Health and relevant stakeholders strengthen health system capacity by making breast cancer screening services more accessible and affordable in rural areas while implementing targeted awareness programs that address specific barriers faced by different demographic groups. Such strategic interventions could significantly improve screening uptake and ultimately contribute to better breast cancer outcomes in rural women in The Gambia.

Acknowledgments

We acknowledge the contributions of Solace Foundation volunteers from the Students of Public Health at Gambia College and Medical Students from the University of The Gambia during data collection. Their dedication and services during this period contributed to the success of this research. We also wish to acknowledge the respondents for their active participation during data collection.

Data Availability

The anonymized data used in this study is protected under the School of Public Health, Gambia College, in accordance with its data protection and privacy framework, for which ethical approval was obtained as stated in the article. Due to these ethical restrictions, the data cannot be made publicly available. However, researchers seeking access to the data may submit requests to Solomon P.S. Jatta, the designated institutional representative for external communications, at spsjatta@gambiacollege.edu.gm. Solomon P.S. Jatta was not involved in this study and is not listed as an author. The institution ensures the long-term preservation and security of the data through a structured data protection and privacy system, with copies maintained in two independent locations to safeguard its integrity and accessibility.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23. doi: 10.1016/j.breast.2022.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pal A, Taneja N, Malhotra N, Shankar R, Chawla B, Awasthi AA, et al. Knowledge, attitude, and practice towards breast cancer and its screening among women in India: a systematic review. J Cancer Res Ther. 2021;17(6):1314–21. doi: 10.4103/jcrt.JCRT_922_20 [DOI] [PubMed] [Google Scholar]
  • 3.WHO. Breast cancer [Internet]. 2024. [cited 2024 Mar 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer [Google Scholar]
  • 4.Globocan. The Republic if The Gambia Fact sheets [Internet]. 2021. [cited 2023 Mar 2]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/270-the-republic-of-the-gambia-fact-sheets.pdf [Google Scholar]
  • 5.Ministry of Health. Health Policy 2021 - 2030. 2021.
  • 6.Espina C, McKenzie F, dos-Santos-Silva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Ann Epidemiol. 2017;27(10):659-671.e7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kohler RE, Gopal S, Miller AR, Lee CN, Reeve BB, Weiner BJ, et al. A framework for improving early detection of breast cancer in sub-Saharan Africa: a qualitative study of help-seeking behaviors among Malawian women. Patient Educ Couns. 2017;100(1):167–73. doi: 10.1016/j.pec.2016.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pace LE, Shulman LN. Breast Cancer in Sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739–44. doi: 10.1634/theoncologist.2015-0429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kinteh B, Kinteh S, Jammeh A, Touray E, Barrow A. Breast cancer screening: Knowledge, attitudes, and practices among female university students in The Gambia. BioMed Res Int. 2023;2023:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.GBoS. Distribution of Population by Gender and LGa [Internet]. Gambia Bureau of Statistics; 2013. [cited 2020 Aug 25]. Available from: https://www.gbosdata.org/topics/population-and-demography/percentage-distribution-of-the-population-by-lga-a/download/pdf [Google Scholar]
  • 11.Lopez-Verdugo F, Mali M, Moustafa M, Nellermoe J, Sorensen J, Bittaye M, et al. Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: A cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2021;30(7_Supplement):19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sanyang O, Lopez-Verdugo F, Mali M, Moustafa M, Nellermoe J, Sorensen J, et al. Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study. BMC Health Serv Res. 2021;21(1):943. doi: 10.1186/s12913-021-06963-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.GBoS. The Gambia Bureau of Statistics (GBoS), Ministry of Health (MoH) [The Gambia], and ICF. 2020. The Gambia Demographic and Health Survey 2019-20: Key Indicators Report. Banjul, The Gambia and Rockville, Maryland, USA: The Gambia Bureau of Statistics, Ministry of Health, and ICF. 2020. [Google Scholar]
  • 14.Dollar to Gambian Dalasi. Dollar to Gambian Dalasi Exchange Rate Today, Live 1 USD to GMD = 51.1606 (Convert Dollars to Gambian Dalasi) [Internet]. 2021. [cited 2021 Apr 29]. Available from: https://www.exchangerates.org.uk/Dollars-to-Gambian-Dalasi-currency-conversion-page.html [Google Scholar]
  • 15.Abo Al-Shiekh SS, Ibrahim MA, Alajerami YS. Breast Cancer Knowledge and Practice of Breast Self-Examination among Female University Students, Gaza. Sci World J. 2021;2021:6640324. doi: 10.1155/2021/6640324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ramathuba D, Ratshirumbi C, Mashamba T. Knowledge, attitudes and practices toward breast cancer screening in a rural South African community. Curationis. 2015;38(1):8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Assfa Mossa K. Perceptions and knowledge of breast cancer and breast self-examination among young adult women in southwest Ethiopia: application of the health belief model. PLoS One. 2022;17(9):e0274935. doi: 10.1371/journal.pone.0274935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tewelde B, Tamire M, Kaba M. Breast self-examination practice and predictors among female secondary school teachers in Addis Ababa, Ethiopia: using the health belief model. BMC Womens Health. 2022;22(1):317. doi: 10.1186/s12905-022-01904-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ifediora C, Azuike E. Tackling breast cancer in developing countries: insights from the Knowledge, Attitudes and Practices on breast cancer and its prevention among Nigerian teenagers in secondary schools. J Prev Med Hygiene. 2018;59:E282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gabriel OE, Ajetunmobi OA, Shabi OM, Elegbede OT, Okere RA, Busari OA, et al. Awareness and practice of self breast examination among female nurses at the federal teaching hospital Ido-Ekiti, Nigeria. J Public Health Afr. 2016;7(1):528. doi: 10.4081/jphia.2016.528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Godfrey K, Agatha T, Nankumbi J. Breast cancer knowledge and breast self-examination practices among female university students in Kampala, Uganda: a descriptive study. Oman Med J. 2016;31(2):129–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sama C, Dzekem B, Kehbila J, Ekabe C, Vofo B, Abua N. Awareness of breast cancer and breast self-examination among female undergraduate students in a higher teachers training college in Cameroon. Pan African Medical J. 2017;28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Asmare K, Birhanu Y, Wako Z. Knowledge, attitude, practice towards breast self-examination and associated factors among women in Gondar town, Northwest Ethiopia, 2021: a community-based study. BMC Women’s Health. 2022;22(1):174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hamed E, Alemrayat B, Syed M, Daher-Nashif S, Rasheed H, Kane T. Breast cancer knowledge, attitudes and practices amongst women in Qatar. Int J Environ Res Public Health. 2022;19(7):3995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Nwaneri A, Emesowum A, Osuala E, Okoronkwo I, Okpala P, Adeyemo F. Practice of breast self-examination among rural women in Umuowa, Orlu government area, Imo state, Nigeria. Int J Community Med Public Health. 2016;3(5):1516–24. [Google Scholar]
  • 26.Selvam M, Sundaram S. Breast self-examination practices among young rural women and its associated knowledge and attitudes in Tirunelveli District, Tamil Nadu. J Cancer Res Ther. 2024;20(1):62–70. doi: 10.4103/jcrt.jcrt_713_22 [DOI] [PubMed] [Google Scholar]
  • 27.Israel E, Awoke N, Yakob T, Aynalem A, Talto A, Bezabih K. Determinants of breast self-examination practice among women attending pastoralist health facilities, Southern Ethiopia: a cross-sectional study. BMC Womens Health. 2023;23(1):14. doi: 10.1186/s12905-023-02158-w [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Denekew Bitew Belay

5 Nov 2024

PONE-D-24-19264Exploring Breast Cancer Awareness and Screening Practices Amongst Gambian Women in the Gambia; Community-based- cross-sectional studyPLOS ONE

Dear Dr. Kinteh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 20 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Denekew Bitew Belay, Ph.D

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the online submission form, you indicated that [The data used to support the findings of this study are available from the Corresponding author upon reasonable request at: bakarykinteh461@gmail.com]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

3. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

4. Please include a separate caption for each figure in your manuscript.

Additional Editor Comments (if provided):

The authors used the two different terms in the study "multivariate logistic regression” and "multivariable logistic regression “interchangeably. Please use the later term consistently.

The authors used "multivariable logistic regression” and use this term throughout. The overall writings should be revised.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have described findings from of breast cancer awareness and screening practices among rural Gambian women in a community-based cross-sectional study. Although awareness was high with 87.7% of women being aware of breast cancer, only 13% practised screening.

Major issues;

1-The distance or proximity of the closest medical facility to the subjects. What kind/level of service are they able to receive, when available?

2-Did cultural or religious practice affect the practice of screening for breast cancer seeing the rather low number (13%) in relation to an 87.7% awareness level of cancer. These were not explored in the study. It will be helpful to give more information on factors that could influence your results such as cultural beliefs, healthcare infrastructure, and accessibility.

3-study design and setting – what health facility is located in this study areas, how accessible are they to study subjects and what infrastructure is on ground to help with breast cancer detection? Providing detailed information on the healthcare infrastructure or specific barriers faced by women in accessing these services will be helpful in appreciating the magnitude of the problem to readers.

Minor issues;

1. What informed the choice of rural women for this study seeing similar study had been done in female undergraduate students in the past?

2. Strengths and limitations (page 11) – although the population is nearly homogeneous for example proximity to health care facility with screening services could affect their screening practices regarding breast cancer.

Reviewer #2: Topic: Exploring Breast Cancer Awareness and Screening Practices amongst Gambian Women in the Gambia; Community-based- cross-sectional study

Dear Editor PLos One Journal,

Many thanks for the opportunity to review this paper from the Gambia. I am grateful.

General Comments

A good and interesting paper. It adds to the breast cancer literature from the Gambia. However, the topic needs revision.

The background outlined the key issues related to breast cancer awareness and screening practices in the Gambia

The statistical analysis were appropriate

The findings presented were relevant and the discussion gave an in-dept explanation on the topic.

Conclusion: the conclusion is generally sound and based on the findings; however, it needs a slight revision.

Specific Comments

1. Tropic: One of the study variables looked at nationality: Gambian and non-Gambino. Therefore, the authors should consider removing the term Gambian on the topic. The proposed topic should read, "EExploring Breast Cancer Awareness and Screening Practices amongst Women in the Gambia: A Community-Based cross-sectional Study.”

2. What was the justification to choose simple random sampling to select participants in households with more than a single eligible respondent on line 130-131? Secondly, how were/were households with no eligible respondent dealt with in the study?

3. Were the research assistant from Solace foundation trained for the data collection at the community level?

4. In Table 1 and table 2, authors were using participants and in other tables respondents. They should be consistent with the terms. Table 2 should read “Breast cancer awareness of respondents.”

5. In lines 202 and 207, the term “our respondents” should be changed to “the respondents” all throughout the document.

6. Table 2: all variables with multiple respondents should be indicated, eg “ Knew the preventive methods of breast cancer risk.”

7.Line 239 Kinteh et al , no year was added to the reference. Similar to Sanyang et al., line 290. Therefore, it should be rephrased

8. Conclusion Line 330-332: “The predictors of breast cancer screening practices were influenced by the parity of the women and the current occupation of the respondents” . Do they mean ethnicity? Parity was not, even though some of its sub categories indicated so.

Reviewer #3: The article provides interesting findings on breast cancer in The Gambia. I think the paper is worthy of publication, but I have a few questions and suggestions for improvement with regard to the methodology and the evaluation strategy.

The authors should better justify the statistical model they chose with mathematical expressions for the models. The descriptive results are not sufficient, charts can be used to support the results.

Although, the article demonstrated scholarly argument, the article is poorly written with a lot of typos and grammatical errors. The paper needs some editing and proof-reading as well as some double-check for consistency in spelling ( I have indicated some out of so many).

Accept with major revision

Reviewer #4: General comment

The study aimed to explore breast cancer awareness and screening practices of rural Gambian women. This is titled “Exploring Breast Cancer Awareness and Screening Practices 1 Amongst Women in The Gambia; Community-based- cross-sectional study”. The study is premised on the limited strategies for addressing breast cancer in The Gambia.

Major comment

Research on breast is laudable. However, the more specific and focused research is, the better. The study focused is inadequately articulated and contextualised. Absence of the operational definition of the main outcome variable of interest is a concern. Nonetheless, I suggest the authors focus solely on breast cancer screening practices.

Specific comments

Title:

• I suggest modification of the title to read as “Barriers and associated characteristics of breast Cancer Screening Practices amongst women in northern part of The Gambia;”

Abstract:

• Background

o Lines 20-21: could be replaced with justification relating to breast cancer screening practices

o Line 22: study objective may thereafter reflect the modified title.

• Methods: consider recasting the statement to reflect the following

o Line 25: Why among rural women?? This is not reflected in the body of the work

o Lines 26-27: authors should recast … interviews may be conducted using structured questionnaires deploy using Kobo toolbox

o Line 28: delete the phrase “SPSS version 28” - Avoid inclusion of software in abstract.

o Line 29: … to determine correlation?? Pearson Chi-square is used to examine association between two categorical variables

o Line 30: replace test with model

o Provide a statement to indicate that adjusted odds ratios was reported in the Results section

• Results:

o Line 34: replace the pronoun “our” with “the”, avoid the use of such pronoun as much as possible

o Lines 36-37: I could not find the result in the body of the work to justified the inclusion of the statement as “risk factors”. However, I guess the authors meant to say respondents’ characteristics

o Lines 39-42: please improve on the reporting style for the statement as only occupation and parity are reported.

• Conclusions:

o Line 43: average of what??? The statement is unclear!

o Line 44: what makes it optimal ... this is not indicated in the result nor in the method section

o Line 45: ... could not be traced to any of the result presented in the Results section of the abstract. Nonetheless, if the suggested title is sustained, it could be appropriate provided that it is linked to the results section.

Introduction:

o Lins 58-59: the statement requires appropriate referencing

o Lines 83-86: the two statements are contradictory; first, lack of knowledge and second, good knowledge

o Line 99 as commented earlier – operational definition of the main outcome of interest is required

o The study justification is rather weak with respect to with the BC awareness or its screening practice among the target population, Most importantly, non-inclusion of the targeted population known practices towards BC screening

Methods:

• Study design and setting

o Lines 107-111: Authors should mention no of districts per the Local government authorities in the northern part of the Gambia. This should be followed by the average numbers of communities per district. Expectedly, the setting should also include the spread of the screening centres

• Sample size determination

o Line 120: the statement “confidence interval of 99% with 50% precision” is unclear! Cross sectional one population study estimated sample size usually utilised within 1 – 5% level of precision. Authors are advised to state the correct parameters used to arrive at 985 as the estimated sample size.

• Sampling strategy

o Lines 123-125: This is not a selection stage.

o Lines 125-131: Questions that ought to have been answered by the “setting” section

Districts selected - out of how any districts?? Total districts in each LGAs should have been mentioned under the study setting

what is the average community per district??

How many households selected per community???

how many participants selected per household ... where more than one was eligible??

• Data collection and management

o Line 132: replace the sub-section title with “Data collection instruments”

o Line 150: it may be necessary to provide justification for using 3 local languages

• Authors are advised to insert a subsection titled “Study variables”. This should clearly state the operational definition of the outcome variable and the selected characteristics of the women.

• Statistical analysis

o Line 158: replace the sub-section title with “Data management and analysis”

o Lines 164-165: replace with “All analysis was conducted at a 5% level of significance”

Results:

• insert “Women’s characteristics” as a subsection

• Line 175: How figure (1012) was obtained needs to be clearly stated in the Methods - sampling strategy subsection

• Association of the selected women’s characteristics and breast cancer screening

o Line Technically, the statement “In total, 529 households were included in the study, with 273 children aged 12-59 months enrolled” could be not right. More than a child could come from a household but NOT the other way round.

o Again, there is no table/figure that is referenced

• Table 1

o While combining the distribution of women by their characteristics and the characterises association with breast cancer is welcome, I will suggest that

o 1. Total column should come before the columns for Yes and No for breast cancer screening

o 2. Yes and No columns of breast cancer screening percentages should be presented in row-wise”.

o The use of chi-square becomes inappropriate in situations where there is zero value in any of the contingency table cells

o Authors should ensure all the variables listed in Table 1 are clearly defined under the methods, study variables subsection

o Table 2 – should appear before the presentation of the “Association between the selected women characteristics and the breast cancer screening practice

• Discussion

• The unclear focus of the study, lines 234-237 in particular, is a concern here. Nonetheless, authors are advised to avoid writing the results under the discussion section – see lines 302 – 317

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Francis Akor

Reviewer #2: No

Reviewer #3: Yes:  OLUWAYEMISI OYERONKE ALABA

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOS ONE REVIEWERS COMMENTS.docx

pone.0307785.s001.docx (15.7KB, docx)
Attachment

Submitted filename: Breast cancer review.docx

pone.0307785.s002.docx (11.8KB, docx)
Attachment

Submitted filename: PONE-D-24-19264.pdf

pone.0307785.s003.pdf (859.4KB, pdf)
PLoS One. 2025 May 12;20(5):e0307785. doi: 10.1371/journal.pone.0307785.r003

Author response to Decision Letter 0


2 Dec 2024

November 14, 2024

Manuscript ID: [PONE-D-24-19264] - [EMID:b560eba95e797023]

Title: “Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional Study”

RE: Revised manuscript submission and response to reviewers’ comments

Dear Editor,

This letter is in reference to your email dated November 5, 2024 with reviewers’ comments. We are very pleased that the manuscript is potentially acceptable for publication in PLOS ONE once we have carried out the revisions.

We would like to thank the reviewers for these insightful and helpful comments and for giving us the chance to revise our manuscript. We believe the revised manuscript has been significantly improved and the reviewers’ comments have been addressed adequately. We think in its current form it will make a valuable contribution to the literature on this increasingly important topic.

Please find for your kind consideration the following:

• A section-by-section response to the comments and suggestions of the reviewers (below).

• The revised manuscript, provided as a marked-up copy and a clean copy.

We hope that these changes meet with your favourable consideration. Please do not hesitate to get in touch if you require any further information.

Bakary Kinteh

Corresponding Author

Reviewer #1:

The authors have described findings from of breast cancer awareness and screening practices among rural Gambian women in a community-based cross-sectional study. Although awareness was high with 87.7% of women being aware of breast cancer, only 13% practised screening.

Major issues;

1-The distance or proximity of the closest medical facility to the subjects. What kind/level of service are they able to receive, when available?

Response: The specifics of available services are beyond the scope of this paper. We appreciate your insights on this and this is clearly acknowledged as a limitation of this study. We assume that assessing the quality and accessibility of available screening services could be helpful in understanding the observed screening patterns.

2-Did cultural or religious practice affect the practice of screening for breast cancer seeing the rather low number (13%) in relation to an 87.7% awareness level of cancer. These were not explored in the study. It will be helpful to give more information on factors that could influence your results such as cultural beliefs, healthcare infrastructure, and accessibility.

Response: You are right we could account for additional potential confounders and even effect modifiers by including variables such as religion, cultural beliefs, healthcare infrastructure and social support systems. These could be future research directions for research in this domain of women’s health. Thank you for bringing this to our attention.

3-study design and setting – what health facility is located in this study areas, how accessible are they to study subjects and what infrastructure is on ground to help with breast cancer detection? Providing detailed information on the healthcare infrastructure or specific barriers faced by women in accessing these services will be helpful in appreciating the magnitude of the problem to readers.

Response: We have now revised the study design and setting section as suggested. Thank you.

Minor issues;

1. What informed the choice of rural women for this study seeing similar study had been done in female undergraduate students in the past?

Response: Our decision was informed by several critical factors. While previous studies among female university students provided valuable insights into breast cancer awareness in an educated, urban population, rural women (constituting approximately 55- 60% of The Gambia's female population) face unique challenges including geographical isolation, limited healthcare infrastructure, and financial constraints. Moreover, rural women often present with late-stage breast cancer due to delayed healthcare seeking, making them a crucial yet understudied population. Understanding their screening practices and barriers is essential for developing targeted interventions and informing health policies aimed at reducing rural-urban health disparities. Therefore, this study complements, rather than duplicates, previous research by addressing a critical knowledge gap in breast cancer screening practices among a vulnerable and underserved population.

2. Strengths and limitations (page 11) – although the population is nearly homogeneous for example proximity to health care facility with screening services could affect their screening practices regarding breast cancer.

Response: Thank you for the insights and we have now expanded on our study limitation as expected.

Reviewer #2:

Topic: Exploring Breast Cancer Awareness and Screening Practices amongst Gambian Women in the Gambia; Community-based- cross-sectional study

Dear Editor PLos One Journal,

Many thanks for the opportunity to review this paper from the Gambia. I am grateful.

General Comments

A good and interesting paper. It adds to the breast cancer literature from the Gambia. However, the topic needs revision.

The background outlined the key issues related to breast cancer awareness and screening practices in the Gambia

The statistical analysis were appropriate

The findings presented were relevant and the discussion gave an in-dept explanation on the topic.

Conclusion: the conclusion is generally sound and based on the findings; however, it needs a slight revision.

Response: We appreciate your insightful comment, Thank you.

Specific Comments

1. Topic: One of the study variables looked at nationality: Gambian and non-Gambian. Therefore, the authors should consider removing the term Gambian on the topic. The proposed topic should read, "Exploring Breast Cancer Awareness and Screening Practices amongst Women in the Gambia: A Community-Based cross-sectional Study.”

Response: We now updated the title as suggested and we have also improved our study’s eligibility criteria to adequately address our inclusion and exclusion criteria.

2. What was the justification to choose simple random sampling to select participants in households with more than a single eligible respondent on line 130-131? Secondly, how were/were households with no eligible respondent dealt with in the study?

Response: Simple random sampling was chosen for selecting participants within households with multiple eligible respondents to ensure equal probability of selection and minimize selection bias that could arise from convenience sampling or voluntary participation. This method helped prevent overrepresentation of more available household members (e.g., unemployed or housewives) who might have different screening behaviors. Regarding households without eligible respondents, these were documented and factored into our response rate calculations to maintain methodological transparency, with replacements systematically selected from the next household in a predetermined direction until we achieved our target sample size. We have reflected these strategies in the manuscript as suggested. Thank you.

3. Were the research assistant from Solace foundation trained for the data collection at the community level?

Response: Yes, all research assistants underwent standardized training conducted by the Solace Foundation, which included instruction on data collection using the Kobo Toolbox, interviewing techniques, and translation protocols for three major local languages (Mandinka, Wolof, and Fula). Prior to field deployment, the trained research assistants participated in a pilot study in the West Coast Region to ensure proficiency in data collection procedures and consistency in questionnaire administration.

4. In Table 1 and table 2, authors were using participants and in other tables respondents. They should be consistent with the terms. Table 2 should read “Breast cancer awareness of respondents.”

Response: We now change all of them to respondents as suggested.

5. In lines 202 and 207, the term “our respondents” should be changed to “the respondents” all throughout the document.

Response: We now change all of them to respondents as suggested.

6. Table 2: all variables with multiple respondents should be indicated, eg “ Knew the preventive methods of breast cancer risk.”

Response: This is implemented as suggested. Thank you.

7.Line 239 Kinteh et al , no year was added to the reference. Similar to Sanyang et al., line 290. Therefore, it should be rephrased

Response: We provide the year and rephrased accordingly. Thank you.

8. Conclusion Line 330-332: “The predictors of breast cancer screening practices were influenced by the parity of the women and the current occupation of the respondents” . Do they mean ethnicity? Parity was not, even though some of its sub categories indicated so.

Response: Thank you for this important clarification. Our conclusion correctly identifies occupation and parity categories (specifically women with two, three, and five children) as significant predictors of breast cancer screening practices, not ethnicity. While ethnicity showed some variations in screening uptake, none were statistically significant (p>0.05). Thank you.

Reviewer #3:

The article provides interesting findings on breast cancer in The Gambia. I think the paper is worthy of publication, but I have a few questions and suggestions for improvement with regard to the methodology and the evaluation strategy.

Response: Thank you for those comments.

The authors should better justify the statistical model they chose with mathematical expressions for the models. The descriptive results are not sufficient, charts can be used to support the results.

Response: We appreciate your suggestion for enhanced statistical presentation. We have now included a detailed mathematical expression of our binary logistic regression model, where logit(p) = ln(p/1-p) = β₀ + β₁X₁ + β₂X₂ + ... + βₖXₖ, with p representing the probability of breast cancer screening practice and β coefficients representing the effects of our predictor variables. This model was chosen due to the binary nature of our outcome variable (screening: yes/no) and its ability to estimate adjusted odds ratios while controlling for multiple predictors simultaneously. To enhance visual interpretation of our results, we have also added a bar chart depicting breast cancer screening practices distribution and another visualizing the main barriers to screening, which complement our tabulated findings and provide a clearer representation of the patterns observed in our data.

Although, the article demonstrated scholarly argument, the article is poorly written with a lot of typos and grammatical errors. The paper needs some editing and proof-reading as well as some double-check for consistency in spelling ( I have indicated some out of so many).

Accept with major revision

Response: We now revised the manuscript and addressed typos and grammatical errors accordingly. Thank you.

Reviewer #4:

General comment

The study aimed to explore breast cancer awareness and screening practices of rural Gambian women. This is titled “Exploring Breast Cancer Awareness and Screening Practices 1 Amongst Women in The Gambia; Community-based- cross-sectional study”. The study is premised on the limited strategies for addressing breast cancer in The Gambia.

Response: Thank you for the comment.

Major comment

Research on breast is laudable. However, the more specific and focused research is, the better. The study focused is inadequately articulated and contextualised. Absence of the operational definition of the main outcome variable of interest is a concern. Nonetheless, I suggest the authors focus solely on breast cancer screening practices.

Response: We have carefully revised the manuscript to sharpen its focus and context, specifically examining both breast cancer awareness and screening practices among rural women in The Gambia. The dual focus is intentional and necessary, as understanding awareness levels provides crucial context for interpreting screening behaviors, particularly in rural settings where health literacy and healthcare access intersect. We have now included clear operational definitions of our outcome variables, with breast cancer screening practice defined as "ever having undergone any form of breast cancer screening (breast self-examination, clinical breast examination, or mammography)." Throughout the manuscript, we have maintained consistent attention to both awareness and screening practices, as these are inextricably linked in the Gambian rural context, where understanding the relationship between knowledge and preventive health behaviors is crucial for developing effective interventions. This approach allows for a comprehensive understanding of the barriers to screening uptake while maintaining a focused analysis of screening practices as our primary outcome of interest.

Specific comments

Title:

• I suggest modification of the title to read as “Barriers and associated characteristics of breast Cancer Screening Practices amongst women in northern part of The Gambia;”

Response: We appreciate your suggested title modification. However, we respectfully prefer to maintain our current title "Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional Study" as it more accurately reflects our study's comprehensive scope, methodology, and findings as suggested by reviewer 2. While barriers and associated characteristics are important components of our analysis, our study examined both awareness and screening practices as interconnected aspects of breast cancer prevention in rural communities. Additionally, our current title explicitly identifies the study design and target population, providing immediate context for readers, and aligns with standard epidemiological reporting guidelines for observational studies.

Abstract:

• Background

o Lines 20-21: could be replaced with justification relating to breast cancer screening practices

o Line 22: study objective may thereafter reflect the modified title.

Response: We have now revised our abstract as suggested. Thank you

• Methods: consider recasting the statement to reflect the following

o Line 25: Why among rural women?? This is not reflected in the body of the work

o Lines 26-27: authors should recast … interviews may be conducted using structured questionnaires deploy using Kobo toolboxo Line 28: delete the phrase “SPSS version 28” - Avoid inclusion of software in abstract.

Response: Implemented as suggested in our revised version. Thank you

o Line 29: … to determine correlation?? Pearson Chi-square is used to examine association between two categorical variables

o Line 30: replace test with model

o Provide a statement to indicate that adjusted odds ratios was reported in the Results section

Response: We have revised and addressed our abstract’s method section accordingly. Thank you.

• Results:

o Line 34: replace the pronoun “our” with “the”, avoid the use of such pronoun as much as possible

o Lines 36-37: I could not find the result in the body of the work to justified the inclusion of the statement as “risk factors”. However, I guess the authors meant to say respondents’ characteristics

o Lines 39-42: please improve on the reporting style for the statement as only occupation and parity are reported.

Response: Implemented as suggested in our revised version. Thank you

• Conclusions:

o Line 43: average of what??? The statement is unclear!

o Line 44: what makes it optimal ... this is not indicated in the result nor in the method section

o Line 45: ... could not be traced to any of the result presented in the Results section of the abstract. Nonetheless, if the suggested title is sustained, it could be appropriate provided that it is linked to the results section.

Response: We have revised our conclusion and all your concerns are adequately addressed. Thank you

Introduction:

o Lins 58-59: the statement requires appropriate referencing

o Lines 83-86: the two statements are contradictory; first, lack of knowledge and second, good knowledge

o Line 99

Attachment

Submitted filename: Response to reviewers.docx

pone.0307785.s006.docx (31.6KB, docx)

Decision Letter 1

Denekew Bitew Belay

2 Jan 2025

PONE-D-24-19264R1Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional StudyPLOS ONE

Dear Dr. Kinteh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Denekew Bitew Belay, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #4: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #4: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Well done for the responses to the queries and with the modifications as suggested in the reviews. No further comments from me

Reviewer #2: No further comments. All comments and concerns have been adequately addressed by the authors.

The paper adds valuable literature of breast cancer awareness to the Gambia.

Reviewer #4: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Francis Akor

Reviewer #2: Yes:  Jainaba Sey-Sawo

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-24-19264_RFA.pdf

pone.0307785.s005.pdf (122.2KB, pdf)
PLoS One. 2025 May 12;20(5):e0307785. doi: 10.1371/journal.pone.0307785.r005

Author response to Decision Letter 1


10 Jan 2025

Our reference list is maintained. Papers cited are not retracted.

Attachment

Submitted filename: Response_to_reviewers_auresp_2.docx

pone.0307785.s008.docx (25.3KB, docx)

Decision Letter 2

Denekew Bitew Belay

14 Jan 2025

PONE-D-24-19264R2Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional StudyPLOS ONE

Dear Dr. Kinteh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Denekew Bitew Belay, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The reviewer’s comments and concerns need to be carefully addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: The comment is attached!

The responses to the comments are appreciated. However, I would like to see the following comments addressed in order to further enriched the manuscript.

Specific comments

Abstract:

• Background:

o Lines 21-23: replaced with the statement “This study aimed to assess breast

cancer awareness and identify associated factors influencing screening uptake among rural women in The Gambia”

• Methods:

o Line 25: replace the word “Gambia” with “The Gambia”, and elsewhere in the manuscript

o Line 29: replace the phrase “Chi-squared and/or Fisher’s exact test” with “Chi-squared or Fisher’s exact test, as appropriate”

o Line 29: replace the phrase “were reported was in the results.” with “were reported”

• Results:

o Line 36: replace the phrase “Multivariable analysis revealed that students” with “Students”

• Conclusions:

o Lines 43-44: Authors are advised to include result(s) suggesting the phrase “primarily due to limited knowledge of the urgent need for accessible and affordable screening services” in the Results section of the abstract

o Lines 44-45: Let the recommendation statement be presented in a separate sentence.

Material and Methods:

• Study design and setting

o Lines 94: the phrase … northern region of … should be addressed as commented earlier

o Line 105: I suggest the deletion of the phrase “Healthcare Access and Barriers”

o Lines 105-115: There is a need to reference some of the factual statements in the paragraph

• Study population and eligibility criteria

o Line 119: replace with “Study population”

• Sample size determination

o Lines 146-148: Authors should ensure the correctness of the following stated figures!

1. Estimated minimum sample size becomes 1103 (not 1092 as indicated) if adjusted for 10% non-response with 1.5 design effect

2. Besides, let’s assume 1092 is correct! Then, only of 1012 (not 1092) that 97.3% response rate would yield 985 completed the study

• Sampling strategy

o Lines 151-162: replace with “A four-stage sampling method was employed. First, the northern region was purposively selected due to its geographical location, high population density of underserved rural women, and absence of mammography services. This selection aligns with the study's aim of understanding screening uptake in rural, as it represents a significant proportion of rural communities with limited healthcare access. The northern region of The Gambia comprises of Kerewan and Kuntaur local government areas (LGAs), with four (Upper Baddibu, Lower Baddibu, Central Baddibu, and Jokadu) and three (Upper Saloum, Lower Saloum, and Niani) districts, respectively. Second, five communities were randomly selected from each district, yielding 35 study communities in total. Third, within each selected community, households were sampled using probability proportional to size, selecting an average of 25-35 households per community. Finally, one eligible woman was selected from each household.”

o Also important to note, selection of 25-30 households in each of the 35 communities would not yield the minimum sample size estimated (30*35=1050; this cannot lead to 1092 assuming its correct). However, 25-35 households per community will do!

• Data management and statistical analysis

o Lines 197-199: The women age was not covered with the present statement. I refer the authors to my previous advice to replace the statement with “Descriptive statistics such as means with standard deviations (SD) for continuous variables, and frequencies and percentages for categorical variables were used present the women characteristics including their breast cancer awareness and screening practices”.

o Line 199: replace “We employed Pearson's chi-squared and/or Fisher’s exact test to” with “As appropriate, Pearson's chi-squared or Fisher’s exact test was used to … ”

o Lines 204-207: Authors are advised to place the statement “Despite its non-significance at the bivariate analysis level, ethnicity was retained in the model owing to its theoretical importance and our specific interest in understanding its effects on breast cancer screening uptake in relation to other predictors” immediate on line 211 after “bivariate level.” to facilitate a smooth narrative.

Results:

• Figure 1:

o Line 251: replace “practices” with “uptake”

• Table 1

o For sake of clarity to the potential Plos One readers, my previous suggestion is necessary!

Column 2 to be presented as Total (column percentage), while others remain as they were

By so doing, statements on women’s characteristic in lines 240-247 could be referenced adequately.

o Additionally, I suggest that the title should read as “Distribution of women’s socio-demographic characteristics by breast cancer screening uptake

• Lines 291: I suggest the paragraph subsection title be read as “Breast cancer screening practices” as this includes BC signs and symptoms.

• Lines 299-302: The statement “These findings highlight the complex interplay of structural, knowledge-based, and personal barriers influencing breast cancer screening uptake in this rural population, suggesting the need for targeted interventions to address these multiple barriers to screening.” should be moved under Discussion section

Thank you!

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #4: Yes:  Rotimi Felix Afolabi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-24-19264R2_RFA.pdf

pone.0307785.s007.pdf (134.5KB, pdf)
PLoS One. 2025 May 12;20(5):e0307785. doi: 10.1371/journal.pone.0307785.r007

Author response to Decision Letter 2


23 Jan 2025

We have realized that an article published by Ramya Ahmad et al, 2019 is a retracted paper and removed from our citation and references list.

Attachment

Submitted filename: Response to reviewers_2025.docx

pone.0307785.s010.docx (23.8KB, docx)

Decision Letter 3

Denekew Bitew Belay

16 Feb 2025

PONE-D-24-19264R3Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional StudyPLOS ONE

Dear Dr.  Kinteh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by  Apr 02 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Denekew Bitew Belay, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: The authors are commended for their efforts in improving this manuscript. The revisions are largely satisfactory; however, a few comments appear to have been addressed inappropriately, likely due to a misunderstanding of their intent. To ensure clarity, I have relisted those comments below for your reference

Abstract:

• Conclusions:

o Lines 43-44: Authors are advised to include result(s) suggesting the phrase “primarily due to limited knowledge of the urgent need for accessible and affordable screening services” in the Results section of the abstract

• The comment requests that the authors report the reasons for the poor uptake of breast cancer screening. Simply referencing “limited knowledge” without presenting supporting data in the Results section would be inappropriate.

• Besides, it is not necessary to include those percentages under the Conclusion section of the abstract. It is better reported under the Results section.

Sample size determination

• Lines 146-148: Authors should ensure the correctness of the following stated figures!

1. Estimated minimum sample size becomes 1103 (not 1092 as indicated) if adjusted for 10% non-response with 1.5 design effect

2. Besides, let’s assume 1092 is correct! Then, only of 1012 (not 1092) that 97.3% response rate would yield 985 completed the study

• Regardless of the statistical software used for sample size computation, the minimum sample size of 662 is accurate based on the presented indices. However, when accounting for the design effect, the minimum sample size increases to 993 (662 * 1.5). If we then adjust for a 10% non-response rate, the required sample size becomes 1103 (993 * 0.9).

• Authors are requested to address this appropriately!

Results:

• Table 1

o For sake of clarity to the potential Plos One readers, my previous suggestion is necessary!

Column 2 to be presented as Total (column percentage), while others remain as they were

By so doing, statements on women’s characteristic in lines 240-247 could be referenced adequately.

• The comments request that the authors include column percentages for the Total column. To avoid any further confusion, I suggest renaming the Total column heading to “n (%)” so that the reported percentages are clearly indicated on a column-wise basis (NOT 100, as presently reported).

Thank you!

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #4: Yes:  Rotimi Felix Afolabi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-24-19264R3_RFA.pdf

pone.0307785.s009.pdf (154.5KB, pdf)
PLoS One. 2025 May 12;20(5):e0307785. doi: 10.1371/journal.pone.0307785.r009

Author response to Decision Letter 3


24 Feb 2025

February 21, 2025

Manuscript ID: [PONE-D-24-19264R3] - [EMID:f65fe664dcb5c3e7]

Title: “Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional Study”

RE: Revised manuscript submission and response to reviewers’ comments

Dear Editor,

This letter is in reference to your email dated February 17, 2025 with reviewers’ comments. We are very pleased that the manuscript is potentially acceptable for publication in PLOS ONE once we have carried out the revisions.

We would like to thank the reviewers for these insightful and helpful comments and for giving us the chance to revise our manuscript. We believe the revised manuscript has been significantly improved and the reviewers’ comments have been addressed adequately. We think in its current form it will make a valuable contribution to the literature on this increasingly important topic.

Please find for your kind consideration the following:

• A section-by-section response to the comments and suggestions of the reviewers (below).

• The revised manuscript, provided as a marked-up copy and a clean copy.

We hope that these changes meet with your favorable consideration. Please do not hesitate to get in touch if you require any further information.

Bakary Kinteh

Corresponding Author

Review’s comments

Abstract:

• Conclusions:

o Line 43 - 44: Authors are advised to include result(s) suggesting the phrase “primarily due to limited knowledge of the urgent need for accessible and affordable screening services” in the Results section of the abstract

Response: We appreciate your feedback. The abstract has been revised to directly reference the identified barriers from the Results section, including a lack of knowledge (58.7%), service unavailability (13.5%), and financial constraints (13.1%), ensuring consistency between the abstract and the results.

Sampling size determination

o Lines 146-148: Authors should ensure the correctness of the following stated figures!

1. Estimated minimum sample size becomes 1103 (not 1092 as indicated) if adjusted for 10% non-response with 1.5 design effect

2. Besides, let’s assume 1092 is correct! Then, only of 1012 (not 1092) that 97.3% response rate would yield 985 completed the study.

Response: We revised and addressed accordingly. We re-calculated the estimated sample size as designed effect of 662*1.5= 993. We later added 10% of 993 gives us 1092 as the estimated sample size. However, we corrected the response rate of 985/1092*100 = 90.2%. Thank you.

Results:

• Table 1 o For sake of clarity to the potential Plos One readers, my previous suggestion is necessary! ▪ Column 2 to be presented as Total (column percentage), while others remain as they were ▪ By so doing, statements on women’s characteristic in lines 240-247 could be referenced adequately.

Response: We revised and included a column percentage of each variable to ensure clarity to PLOS One readers. Thank you.

Decision Letter 4

Denekew Bitew Belay

28 Feb 2025

Exploring Breast Cancer Awareness and Screening Practices Amongst Rural Women in The Gambia: Community-based Cross-sectional Study

PONE-D-24-19264R4

Dear Dr. Kinteh,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Denekew Bitew Belay, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: The authors are commended for their efforts in improving this manuscript. The revisions are satisfactory.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #4: Yes:  Rotimi Felix Afolabi

**********

Acceptance letter

Denekew Bitew Belay

PONE-D-24-19264R4

PLOS ONE

Dear Dr. Kinteh,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Denekew Bitew Belay

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PLOS ONE REVIEWERS COMMENTS.docx

    pone.0307785.s001.docx (15.7KB, docx)
    Attachment

    Submitted filename: Breast cancer review.docx

    pone.0307785.s002.docx (11.8KB, docx)
    Attachment

    Submitted filename: PONE-D-24-19264.pdf

    pone.0307785.s003.pdf (859.4KB, pdf)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0307785.s006.docx (31.6KB, docx)
    Attachment

    Submitted filename: PONE-D-24-19264_RFA.pdf

    pone.0307785.s005.pdf (122.2KB, pdf)
    Attachment

    Submitted filename: Response_to_reviewers_auresp_2.docx

    pone.0307785.s008.docx (25.3KB, docx)
    Attachment

    Submitted filename: PONE-D-24-19264R2_RFA.pdf

    pone.0307785.s007.pdf (134.5KB, pdf)
    Attachment

    Submitted filename: Response to reviewers_2025.docx

    pone.0307785.s010.docx (23.8KB, docx)
    Attachment

    Submitted filename: PONE-D-24-19264R3_RFA.pdf

    pone.0307785.s009.pdf (154.5KB, pdf)

    Data Availability Statement

    The anonymized data used in this study is protected under the School of Public Health, Gambia College, in accordance with its data protection and privacy framework, for which ethical approval was obtained as stated in the article. Due to these ethical restrictions, the data cannot be made publicly available. However, researchers seeking access to the data may submit requests to Solomon P.S. Jatta, the designated institutional representative for external communications, at spsjatta@gambiacollege.edu.gm. Solomon P.S. Jatta was not involved in this study and is not listed as an author. The institution ensures the long-term preservation and security of the data through a structured data protection and privacy system, with copies maintained in two independent locations to safeguard its integrity and accessibility.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES